Nivolumab (Anti-PD1), Tadalafil and Oral Vancomycin in People With Refractory Primary Hepatocellular Carcinoma or Liver Dominant Metastatic Cancer From Colorectal or Pancreatic Cancers
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
American Regent, Inc.
National Institutes of Health Clinical Center (CC)
Georgetown University
Imunon
BTG International Inc.
SC Liver Research Consortium, LLC
New Mexico Cancer Research Alliance
Gachon University Gil Medical Center
Erasmus Medical Center
Alliance for Clinical Trials in Oncology
Emory University
Cliniques universitaires Saint-Luc- Université Catholique de Louvain
Roswell Park Cancer Institute
City of Hope Medical Center
National Institutes of Health Clinical Center (CC)
Stanford University
Emory University
University of Utah
New Mexico Cancer Research Alliance
Jules Bordet Institute
Assistance Publique - Hôpitaux de Paris
Federation Francophone de Cancerologie Digestive
Auron Healthcare GmbH
European Organisation for Research and Treatment of Cancer - EORTC
Pfizer
Case Comprehensive Cancer Center